There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aquestive Therapeutics Inc (NASDAQ:AQST) and Galapagos NV (NASDAQ:GLPG) with bullish sentiments.
Aquestive Therapeutics Inc (AQST)
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Aquestive Therapeutics Inc, with a price target of $34. The company’s shares opened today at $14.80.
According to TipRanks.com, Moussatos has 0 stars on 0-5 star ranking scale with an average return of -5.8% and a 37.0% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Allena Pharmaceuticals Inc, Global Blood Therapeutics, and Catabasis Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aquestive Therapeutics Inc with a $28 average price target.
See today’s analyst top recommended stocks >>
Galapagos NV (GLPG)
Cowen & Co. analyst Phil Nadeau maintained a Buy rating on Galapagos NV today. The company’s shares opened today at $97.04.
According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 8.5% and a 49.6% success rate. Nadeau covers the Healthcare sector, focusing on stocks such as Rocket Pharmaceuticals Inc, Rhythm Pharmaceuticals Inc, and Alexion Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Galapagos NV with a $115.60 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
